Cannabis and the Liver: Hepatitis, Fibrosis and CBD
The endocannabinoid system is deeply integrated into liver physiology — with a remarkable peculiarity: CB1 on liver cells promotes fibrosis and steatosis, while CB2 on liver macrophages has anti-fibrotic and hepatoprotective effects. THC activates both receptors, whereas CBD modulates the system through other pathways. What hepatology knows about the liver effects of cannabis.
Overview
hide
ECS in the liver: CB1 and CB2 on liver cells
The liver expresses both cannabinoid receptors — with opposing functions:
- CB1 on hepatocytes and stellate cells: CB1 receptors are expressed on liver cells (hepatocytes) and hepatic stellate cells (stellate cells — the main producers of liver scar tissue). CB1 activation on stellate cells promotes their activation into myofibroblasts → increased collagen production → fibrosis. Endogenous CB1 activation is part of the normal fibrosis signaling pathway in liver damage
- CB2 on Kupffer cells: Kupffer cells (liver-resident macrophages) express CB2 receptors. CB2 activation dampens pro-inflammatory activation of Kupffer cells → reduced TNF-α and IL-1β production → less hepatic inflammation → slowed fibrosis development
- THC activates CB1 and CB2: Exogenous THC activates both receptors simultaneously. CB1 activation on stellate cells promotes fibrosis; CB2 activation on Kupffer cells inhibits inflammation. The net effect is dose-dependent and differs between acute vs. chronic consumption
- FAAH in the liver: FAAH (the anandamide-degrading enzyme) is highly expressed in the liver. CBD inhibits FAAH → increased anandamide → moderated CB1/CB2 activation. This mechanism explains partly the different liver effects of THC (direct CB1 agonist) vs. CBD (indirect modulator)
THC and liver fibrosis: Hepatitis C as a critical context
The clinically significant data come from Hepatitis C research:
- Naveau et al. 2004 (Hepatology): Prospective study with 270 HIV/HCV co-infected patients. Daily cannabis use was the strongest independent risk factor for accelerated liver fibrosis progression — stronger than alcohol in this cohort. Adjusted OR 3.0 for significant fibrosis with daily use
- Hézode et al. 2005 (Gut): 270 HCV patients without HIV. Daily cannabis use associated with higher fibrosis rate (F2–F4 according to Metavir) — dose-dependent. Mechanism: direct CB1 activation on stellate cells → fibrosis acceleration. Occasional use (less than daily) showed no significant effect
- Mechanism: In chronic hepatitis C, the liver is permanently inflamed and in active remodeling — stellate cells are already sensitized. Additional CB1 stimulation through THC gives these cells an additional pro-fibrotic stimulus. In a healthy liver without underlying disease, this effect is less clinically relevant.
- Hepatitis B: Less data, but a mechanistically similar risk assessment seems plausible. Patients with active hepatitis B and regular cannabis use should have close fibrosis monitoring
- Alcoholic liver disease: Combined alcohol and cannabis use shows an additive fibrosis effect in some studies. Daily cannabis use is contraindicated in existing alcohol-associated liver disease
CB2 and anti-fibrotic effects: The other side
CB2 agonists show pronounced anti-fibrotic properties in animal models:
- CB2 activation on stellate cells: In contrast to CB1, CB2 activation on hepatic stellate cells inhibits their activation — reduces collagen production and promotes apoptosis of activated stellate cells. CB2 is almost like the “brake” of CB1-mediated fibrosis
- Julien et al. 2005 (Gastroenterology): CB2 knockout mice developed more severe liver fibrosis than wild-type animals after liver injury — proves the physiological anti-fibrotic role of CB2. CB2 agonists significantly reduced fibrosis
- CBD and CB2: CBD has a low but measurable affinity for CB2, inhibits FAAH and activates PPARγ — all anti-fibrotic signaling pathways. CBD shows hepatoprotective effects (antioxidant, CB2-mediated anti-inflammatory) in models of hepatic ischemia and inflammation
- Rimonabant research: The CB1 antagonist Rimonabant showed anti-fibrotic and metabolic effects in liver diseases in clinical studies — but was withdrawn from the market due to psychiatric side effects (depression, suicide). The principle (CB1 blockade in the liver) is valid; suicide-safe peripheral CB1 antagonists are under development
Related
CBD and liver toxicity: High doses are problematic
CBD is often perceived as liver-friendly — this is the opposite when taken in high doses:
- Epidiolex studies (GW Pharmaceuticals): In clinical studies with high-dose CBD (20 mg/kg/day for epilepsy), 5–20% of patients showed elevated liver enzymes (ALT/AST). 3% had clinically significant transaminase increases >3× ULN. The effect was dose-dependent and reversible after discontinuation
- FDA warning: The FDA has explicitly pointed out the risk of liver toxicity at high CBD doses. OTC CBD doses (25–100 mg/day) are considered significantly safer than therapeutic high doses (1,500–2,000 mg/day)
- Valproate interaction: CBD + Valproate (often combined in epilepsy) synergistically increases the risk of hepatotoxicity. With this combination, close monitoring of liver values (every 4–6 weeks) is mandatory. More on interactions: Cannabis and Interactions
- CYP2C9 and CYP3A4: CBD inhibits both enzymes — relevant interactions with medications metabolized via these pathways. In patients with pre-existing liver damage, CYP capacity is already reduced — CBD doses must be adjusted
- Practical consequence: Patients with liver disease should have liver values checked before taking CBD and have them rechecked after 4–6 weeks. In cases of pre-existing elevated transaminases: conservative doses (maximum 50 mg/day) and medical supervision
Cannabis in non-alcoholic fatty liver disease (NAFLD) and metabolic disorders
- CB1 and hepatic lipogenesis: Activation of CB1 in the liver increases fatty acid synthesis (lipogenesis) and inhibits fat oxidation → steatosis (fatty liver). Chronic THC consumption can promote the development of fatty liver in the presence of pre-existing metabolic syndrome. Relation to the diabetes complex: Cannabis and Diabetes
- Epidemiological data — surprising: Cross-sectional studies (Adejumo 2017, PLOS ONE, N=5.7 million) paradoxically show lower NAFLD prevalence among cannabis users. Possible explanation: lower BMI tendency and metabolic effects of occasional vs. daily-heavy consumption. Causality unclear, numerous confounders
- Conclusion for NAFLD: Occasional cannabis use shows no clearly adverse NAFLD effects in epidemiology. Daily heavy consumption in the presence of pre-existing fatty liver and metabolic syndrome: increased progression risk due to CB1 lipogenesis effect. Weigh individual risks, seek medical guidance
Cannabis and the immune system — CB2 on liver macrophages (Kupffer cells):
Buy CBD oil — quality criteria, COA verification and safe dosing — especially relevant with pre-existing liver function: Buy CBD oil.
Frequently asked questions about cannabis and the liver
Related
Infused Kitchen at FIV: The new cannabis cooking portal
Cannabis Drinks: Smoothies, Tea, Golden Milk & Recipes
Cannabis Grillen: BBQ, Marinaden & Rezepte für den Sommer
Infused Kitchen: Cannabis recipes for baking, cooking, grilling & drinks
Social Media Ads: More Sales Through Targeted Online Marketing
Career start after studies: What recruiters are really looking for
More
Internship at Top Companies: Opportunities, Compensation and the Direct Path to a Career
Financing your studies in 2026: Germany Scholarship, BAföG and smart saving tips
Stress triggers: The most common causes at work, in relationships, and finances
Stress Management Techniques: Comparison of MBSR, PME, Sport and Breathing Exercises
Cortisol: The stress hormone, its effects and how to reduce it
Chronic Stress: Effects on Body and Mind, Treatment and Therapy
Stress reduction: What doctors really recommend – causes, symptoms & techniques
Stress symptoms: Recognizing physical and psychological signs
Sleep Disturbances: Insomnia, Sleep Apnea & How Doctors Treat Them Today
Melatonin: Effects, Dosage & when it really helps with sleep
